R
2.28
-0.08 (-3.39%)
| 前收盘价格 | 2.36 |
| 收盘价格 | 2.30 |
| 成交量 | 158,395 |
| 平均成交量 (3个月) | 200,313 |
| 市值 | 104,782,184 |
| 价格/销量 (P/S) | 3.74 |
| 股市价格/股市净资产 (P/B) | 7.55 |
| 52周波幅 | |
| 利润日期 | 13 Jan 2025 |
| 营业毛利率 | -18.03% |
| 营业利益率 (TTM) | -17.98% |
| 稀释每股收益 (EPS TTM) | -0.130 |
| 季度收入增长率 (YOY) | 23.00% |
| 总债务/股东权益 (D/E MRQ) | 23.73% |
| 流动比率 (MRQ) | 2.66 |
| 杠杆自由现金流 (LFCF TTM) | 1.05 M |
| 资产报酬率 (ROA TTM) | -14.47% |
| 股东权益报酬率 (ROE TTM) | -32.64% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 看跌 | 混合的 |
| Medical Instruments & Supplies (全球的) | 看跌 | 混合的 | |
| 股票 | KORU Medical Systems, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
1.5
| 分析师共识 | 3.5 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.50 |
|
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Small Core |
| 内部持股比例 | 7.61% |
| 机构持股比例 | 51.23% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Meros Investment Management, Lp | 31 Dec 2024 | 765,550 |
| Albion Financial Group /Ut | 31 Mar 2025 | 441,374 |
| White Pine Capital Llc | 31 Dec 2024 | 157,917 |
| Highmark Wealth Management Llc | 31 Mar 2025 | 120,935 |
| 52周波幅 | ||
| 中 | 3.50 (53.51%) | |
| 总计 | 1 保留 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Piper Sandler | 08 May 2025 | 3.50 (53.51%) | 保留 | 2.75 |
| 14 Feb 2025 | 4.50 (97.37%) | 保留 | 4.37 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合